Home › Brain and Spinal Cord Tumors › Missouri › St. Louis
Brain and Spinal Cord Tumors clinical trials in St. Louis, MO
5 studies for Brain and Spinal Cord Tumors are looking for participants at sites in and around St. Louis (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
HSV G207 in Children With Recurrent or Refractory Cerebellar Brain Tumors
RecruitingPhase 1
- Siteman Cancer Center at Washington University, St Louis
Project: Every Child for Younger Patients With Cancer
RecruitingObservational study
- Cardinal Glennon Children's Medical Center, St Louis
- Washington University School of Medicine, St Louis
- Mercy Hospital Saint Louis, St Louis
DALY II USA/ MB-CART2019.1 for DLBCL
RecruitingPhase 2
- Washington University, St. Louis, St Louis
Inflammation in Primary and Secondary Malignancies of the Central Nervous System Using [C-11]-CS1P1
RecruitingPhase 2
- Washington University School of Medicine, St Louis
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
RecruitingObservational study
- Massive Bio SYNERGY-AI site, St Louis
Brain and Spinal Cord Tumors trials in other cities
- New York City, NY10 studies
- Houston, TX9 studies
- Nashville, TN7 studies
- Boston, MA7 studies
- Philadelphia, PA7 studies
- Los Angeles, CA6 studies
- Washington, DC6 studies
- Dallas, TX5 studies
- Seattle, WA5 studies
- Columbus, OH5 studies
- Atlanta, GA5 studies
- Chicago, IL5 studies
Other studies in St. Louis
- Non-Small Cell Lung Cancer73 studies
- Breast Cancer64 studies
- Metastatic Cancer54 studies
- Colorectal Cancer50 studies
- Cancer (all types)46 studies
- Prostate Cancer46 studies
- Lung Cancer39 studies
- Ovarian Cancer38 studies
- Pancreatic Cancer33 studies
- Endometrial Cancer29 studies
- Head and Neck Squamous Cell Carcinoma28 studies
- Heart Failure26 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.